drugset / Trial / NCT04345458
Safety and Efficacy Study of Prefilled Liquid Etanercept(Yisaipu) for Active Ankylosing Spondylitis
RandomizedParallel-groupTriple-blindTreatment
Summary
This randomized, double-blind, phase III parallel-group non-inferiority study aimed to investigate the efficacy and safety of prefilled liquid etanercept (Yisaipu) versus lyophilized etanercept powder (Yisaipu) in active ankylosing spondylitis patients.
Timeline
- Start
- 2014-03-06
- Primary completion
- 2015-07-13
- Completion
- 2015-07-20
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Etanercept | Protein / enzyme biologic | 25 mg | — |
| Comparator | Etanercept | Protein / enzyme biologic | 50 mg | — |